This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Facebook-ICC Deal Spurs Competition in India Streaming Space
by Aniruddha Ganguly
Facebook's (FB) ICC deal is expected to help expand its footprint in India's streaming space, currently dominated by Disney's Hotstar and SonyLiv.
Alexandria Expands With $26M Buyout in Stanford Research Park
by Zacks Equity Research
Amid solid demand for life science real estate, Alexandria (ARE) latest buyout comes as part of its strategic focus on expanding in the greater Stanford innovation cluster.
First Solar Inks Series 6 Module Deal With Intersect Power
by Zacks Equity Research
First Solar's (FSLR) Series 6 solar modules are produced in just 3.5 hours using its proprietary thin film technology, offering a performance advantage over conventional solar panels.
3 Blue-Chip Tech Stocks for Investors to Buy Heading into October
by Benjamin Rains
We searched using our Zacks Stock Screener for large-cap technology firms that boast stable, growth businesses. So check out these three blue-chip tech stocks that investors might want to buy heading into October...
Facebook (FB) to Not Remove "Newsworthy" Political Content
by Zacks Equity Research
Facebook (FB) to keep political content even if it violates its standards, and regulate false content and enhance ad transparency measures ahead of U.S. and Singapore elections.
Facebook Agrees to Buy CTRL-labs, Focuses on AR Initiatives (Revised)
by Zacks Equity Research
Facebook (FB) to acquire New York-based startup CTRL-labs, which is developing a technology to let people control computers through brain signal.
The Zacks Analyst Blog Highlights: Facebook, Apple, Perficient and Chegg
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Facebook, Apple, Perficient and Chegg
The Zacks Analyst Blog Highlights: Facebook, UnitedHealth, GlaxoSmithKline, Duke and BlackRock
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Facebook, UnitedHealth, GlaxoSmithKline, Duke and BlackRock
Top Stock Reports for Facebook, UnitedHealth & GlaxoSmithKline
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Facebook (FB), UnitedHealth Group (UNH) and GlaxoSmithKline (GSK).
Consumer Confidence, Netflix and Roku Fall & Buy Columbia Stock - Free Lunch
by Benjamin Rains
U.S. stocks hadn't been moving much in September. Shares of streaming TV firms Netflix and Roku have tumbled. What to expect from Nike's Q1 fiscal 2020 earnings results Tuesday. And why Columbia (COLM) stock is a Zacks Rank #1 (Strong Buy) - Free Lunch